Zeid El-Kilani, MPP

Articles

Projected US Savings From Biosimilars, 2021-2025

January 03, 2022

Projected savings from biosimilars from 2021 to 2025 were $38.4 billion vs conditions as of quarter 4 of 2020 and were driven by new biosimilar entry. Savings were $124.5 billion under an upper-bound scenario.